Epidemiologic Factors Associated with Seropositivity to Human Papillomavirus Type 16 and 18 Virus–Like Particles and Risk of Subsequent Infection in Men

@article{Lu2010EpidemiologicFA,
  title={Epidemiologic Factors Associated with Seropositivity to Human Papillomavirus Type 16 and 18 Virus–Like Particles and Risk of Subsequent Infection in Men},
  author={Beibei Lu and Michael E. Hagensee and Ji‐Hyun Lee and Yougui Wu and Heather G. Stockwell and Carrie M Nielson and Martha Abrahamsen and Mary R. Papenfuss and Robin B Harris and Anna R. Giuliano},
  journal={Cancer Epidemiology, Biomarkers \& Prevention},
  year={2010},
  volume={19},
  pages={511 - 516}
}
Our understanding of humoral response to human papillomavirus (HPV) infection has been mainly derived from studies in women. The role of serum antibodies in the natural history of HPV in men has yet to be investigated. Data from 285 male participants of a natural history study were used to determine the epidemiologic factors associated with HPV 16/18 seropositivity and explore the role of HPV 16 and 18 serum antibodies in subsequent HPV infections. Serum antibodies were detected by use of HPV… 

Tables from this paper

Serum Antibodies to Human Papillomavirus Type 6, 11, 16 and 18 and Their Role in the Natural History of HPV Infection in Men
TLDR
These studies indicate that exposure to HPV 6, 11, 16 and 18, the four HPV types targeted in the currently license HPV vaccines, is common and that seroprevalence of individual vaccine HPV types is greatly elevated among men of different sexual practices.
Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study
TLDR
Investigation of the seroprevalence of 9vHPV vaccine types and associated risk factors among men residing in Brazil, Mexico, and the United States indicates that exposure to the nine HPV types included in the 9v HPV vaccine is common in men and that seropositivity to 9v HPV vaccine types is associated with older age and the lifetime number of anal sex partners.
Human Papillomavirus (HPV) 6, 11, 16, and 18 Seroprevalence Is Associated with Sexual Practice and Age: Results from the Multinational HPV Infection in Men Study (HIM Study)
TLDR
Exposure to vaccine HPV types were common in men and highly prevalent among MSM and MSMW, and strong evidence that the practice of same-sex anal intercourse is an independent risk factor for seroprevalence of individual HPV types is provided.
Impact of Serum Antibodies to HPV Serotypes 6, 11, 16, and 18 to Risks of Subsequent Genital HPV Infections in Men: The HIM Study.
TLDR
Baseline serostatus among men was not associated with a reduction in subsequent incident genital HPV 6, 11, and 16 infections, however, protection against persistent HPV18 infections was observed in unadjusted models.
Human papillomavirus seroprevalence and seroconversion among men living with HIV: Cohort study in South Africa.
TLDR
HPV vaccination of boys before they become sexually active could reduce the burden of HPV infection among this at-risk population of men living with HIV.
Prevalence, Incidence, and Risk Factors for Human Papillomavirus 16 Seropositivity in Australian Homosexual Men
TLDR
Both HPV16 seroprevalence and seroincidence correlated well with markers of higher risk sexual activity, particularly receptive anal sexual practices, suggesting that vaccination may be protective in sexually active young gay men.
Association of Known and Unknown Oncoviruses with External Genital Lesion (EGL) Manifestations in a Multinational Cohort of Men
TLDR
Exposure to cutaneous HPV is common among men residing in Brazil, Mexico, and the U.S, and factors associated with various typespecific cutaneousHPV seropositivity included country, circumcision, and lifetime number of male sexual partners.
An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study
TLDR
No evidence of HPV16 natural antibodies protecting against subsequent genital or anal HPV16 infection in MSM is suggested, which could help partially explain the high incidence of genital and anal HPV 16 infection and related anal cancer seen in middle-aged and older MSM.
Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review.
...
...

References

SHOWING 1-10 OF 32 REFERENCES
Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women
TLDR
The low sensitivity of HPV-16 VLP-based ELISA may limit the usefulness of the assay as a diagnostic test for HPV- 16 infection, but the assay appears to have adequate specificity and should be useful as an epidemiological marker ofHPV-16 infection and sexual behavior.
Seroprevalence of human papillomavirus type 16 infection in the United States.
TLDR
Investigation of the seroepidemiology of HPV-16 infection in the United States by using a population-based survey found age, race/ethnicity, and number of lifetime sex partners were associated with HPV seropositivity in women and men.
Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer
TLDR
Seropositivity to HPV 16 and HPV 6/11/16/18 antigens seem to be better markers of past sexual activity than current HPV infection, and humoral response to HPV 15 or HPV 6-11/ 16/18 may not be a strong indicator of cervical lesions in populations at low risk for cervical lesions.
Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.
TLDR
A sustained high level of IgG antibody to HPV- 16 VLPs was associated with reduced risk for subsequent infection with HPV-16 and its genetically related types.
Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women.
Seroreactivity to human papillomavirus type 16 (HPV-16) virus-like particles (VLPs) in men attending clinics for sexually transmitted diseases (STDs) in Denmark (n = 219) and Greenland (n = 88) was
Short Communication Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection: Results from a Population-Based Study in Costa Rica
TLDR
Seropositivity to HPV-16, HPV-18, or HPV-31 was not associated with a statistically significant decreased risk of infection with the homologous HPV type, and a protective effect from natural infection cannot be excluded because of the limits of available assays and study designs.
Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men.
TLDR
HIV-infected men are able to generate an antibody response to HPV, and a lack of serum HPV antibodies cannot explain the increased HPV-associated disease seen in HIV- Infected men.
Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study.
TLDR
The key factor associated with acquisition of HPV was lifetime number of sex partners, whereas circumcision was the most significant determinant for clearance of any HPV infection and oncogenic HPV infection.
Gender Differences in Sexual Biomarkers and Behaviors Associated With Human Papillomavirus-16, −18, and −33 Seroprevalence
TLDR
HPV seropositivity is associated with sexually transmitted diseases among women and possibly mucosal HPV exposures in men and Tonsillar HPV infection could impact seroprevalence, particularly in men.
Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
TLDR
Sex- and age-related differences in both the seropositivity and seroincidence of HPV-16 antibody persisted after adjustment for behavioral and sociodemographic risk factors, and behavioral risk factors during the preceding 3 months were stronger predictors of theSeroprevalence and seriosexual activity than was lifetime sexual behavior.
...
...